Maximilian C. C. J. C. Ebert

959 citations

23 papers · 706 indexed · 1 hit paper · h-index 14

Molecular Biology
Computational Theory and Mathematics top 5%
Infectious Diseases top 10%
Sensory Systems top 5%
Organic Chemistry

Co-authors: Joelle N. Pelletier Nobuaki Takahashi Yasuo Mori Daisuke Kozai Ryohei Kobayashi Vicky Mody Rangaiah Shashidharamurthy Srujana Rayalam
Topics: Protein Structure and Dynamics (5 papers)Computational Drug Discovery Methods (3 papers)Biochemical and Molecular Research (3 papers)
Cited by: Sensory Systems Computational Theory and Mathematics Pharmacology
Journals: PLoS ONE Biochemistry Nature Methods
Partner nations: Canada United States Germany

In The Last Decade

Maximilian C. C. J. C. Ebert

22 papers receiving 698 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents

2021 188 citations Vicky Mody, Maximilian C. C. J. C. Ebert et al. Communications Biology profile →

Peers

Countries citing papers authored by Maximilian C. C. J. C. Ebert

Since Specialization

Citations

This map shows the geographic impact of Maximilian C. C. J. C. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian C. C. J. C. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian C. C. J. C. Ebert more than expected).

Fields of papers citing papers by Maximilian C. C. J. C. Ebert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian C. C. J. C. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian C. C. J. C. Ebert. The network helps show where Maximilian C. C. J. C. Ebert may publish in the future.

Co-authorship network of co-authors of Maximilian C. C. J. C. Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian C. C. J. C. Ebert. A scholar is included among the top collaborators of Maximilian C. C. J. C. Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian C. C. J. C. Ebert. Maximilian C. C. J. C. Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computational assessment of the binding modes of the first VHL-recruiting PROTACs designed for oncogenic KRas^G12C 2024 ·New Journal of Chemistry ·Tanos C. C. França,(unknown),Michael L. Drummond,Maximilian C. C. J. C. Ebert,(unknown),Steven R. LaPlante	1
2	Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro 2022 ·Scientific Reports ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Maximilian C. C. J. C. Ebert,(unknown),Ajay Singh,Srujana Rayalam,Vicky Mody,Rangaiah Shashidharamurthy	24
3	Functional antibody characterization via direct structural analysis and information‐driven protein–protein docking 2021 ·Proteins Structure Function and Bioinformatics ·Rafael S. Depetris,Dan Lü,(unknown),Zhikai Zhang,(unknown),(unknown),(unknown),Michael L. Drummond,(unknown),Maximilian C. C. J. C. Ebert,Jeegar Patel,Masha V. Poyurovsky	5
4	Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agentsbreakdown → 2021 ·Communications Biology ·Vicky Mody,(unknown),(unknown),(unknown),(unknown),Maximilian C. C. J. C. Ebert,Guillaume Fortin,Srujana Rayalam,Rangaiah Shashidharamurthy	188
5	Monitoring protein conformational changes using fluorescent nanoantennas 2021 ·Nature Methods ·Scott G. Harroun,(unknown),Maximilian C. C. J. C. Ebert,(unknown),Xiaomeng Wang,Alexis Vallée‐Bélisle	20
6	Biomechanical analysis of single-leg stance using a textured balance board compared to a smooth balance board and the floor: A cross-sectional study 2020 ·Gait & Posture ·(unknown),Maximilian C. C. J. C. Ebert,(unknown),Axel J. Knicker	4
7	O2-Dependent Protein Internalization Underlies Astrocytic Sensing of Acute Hypoxia by Restricting Multimodal TRPA1 Channel Responses 2020 ·Current Biology ·Makoto Uchiyama,Akito Nakao,(unknown),(unknown),Kotaro Takeda,Tomohiro Numata,(unknown),Seishiro Sawamura,Maximilian C. C. J. C. Ebert,Tatsuki Kurokawa,Reiko Sakaguchi,Alexander J. Stokes,Nobuaki Takahashi,Yasumasa Okada,Yasuo Mori	31
8	Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases 2020 ·ACS Medicinal Chemistry Letters ·(unknown),Genbin Shi,(unknown),Maximilian C. C. J. C. Ebert,(unknown),Marc Gagnon,Edward H. Ruediger,(unknown),Delphine Forge,Jean Jacques Vanden Eynde,Anne Marinier,Xinhua Ji,Joelle N. Pelletier	11
9	The Structural Dynamics of Engineered β-Lactamases Vary Broadly on Three Timescales yet Sustain Native Function 2019 ·Scientific Reports ·S. Gobeil,Maximilian C. C. J. C. Ebert,Jaeok Park,Donald Gagné,Nicolas Doucet,Albert M. Berghuis,Jürgen Pleiss,Joelle N. Pelletier	19
10	Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues 2019 ·ACS Omega ·(unknown),Brahm J. Yachnin,Edward H. Ruediger,(unknown),Marc Gagnon,(unknown),Maximilian C. C. J. C. Ebert,Delphine Forge,Dominic Bastien,(unknown),Jean Jacques Vanden Eynde,Anne Marinier,Albert M. Berghuis,Joelle N. Pelletier	8
11	Glycine Perturbs Local and Global Conformational Flexibility of a Transmembrane Helix 2018 ·Biochemistry ·(unknown),Alexander Götz,(unknown),Maximilian C. C. J. C. Ebert,Walter Stelzer,Kasper D. Rand,Christina Scharnagl,Dieter Langosch	41
12	Computational tools for enzyme improvement: why everyone can – and should – use them 2017 ·Current Opinion in Chemical Biology ·Maximilian C. C. J. C. Ebert,Joelle N. Pelletier	78
13	Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening 2017 ·PLoS ONE ·Daniela Quaglia,Maximilian C. C. J. C. Ebert,(unknown),Joelle N. Pelletier	20
14	Substrate-Specific Screening for Mutational Hotspots Using Biased Molecular Dynamics Simulations 2017 ·ACS Catalysis ·Maximilian C. C. J. C. Ebert,(unknown),Guillaume Lamoureux,Joelle N. Pelletier	19
15	Evolution of P450 Monooxygenases toward Formation of Transient Channels and Exclusion of Nonproductive Gases 2016 ·ACS Catalysis ·Maximilian C. C. J. C. Ebert,(unknown),(unknown),Guillaume Lamoureux,Joelle N. Pelletier	15
16	Transnitrosylation Directs TRPA1 Selectivity in N-Nitrosamine Activators 2013 ·Molecular Pharmacology ·Daisuke Kozai,(unknown),Maximilian C. C. J. C. Ebert,Shigeki Kiyonaka,Yuko Otani,Tomohiro Numata,Nobuaki Takahashi,Yasuo Mori,Tomohiko Ohwada	19
17	Fragment-Based Design of Symmetrical Bis-benzimidazoles as Selective Inhibitors of the Trimethoprim-Resistant, Type II R67 Dihydrofolate Reductase 2012 ·Journal of Medicinal Chemistry ·Dominic Bastien,Maximilian C. C. J. C. Ebert,Delphine Forge,(unknown),(unknown),(unknown),Annie Mayence,Tien L. Huang,Jean Jacques Vanden Eynde,Joelle N. Pelletier	25
18	Roles of TRPM2 in oxidative stress 2011 ·Cell Calcium ·Nobuaki Takahashi,Daisuke Kozai,Ryohei Kobayashi,Maximilian C. C. J. C. Ebert,Yasuo Mori	135
19	Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure 2011 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Brahm J. Yachnin,(unknown),(unknown),Maximilian C. C. J. C. Ebert,Joelle N. Pelletier,Albert M. Berghuis	9
20	[Differentiation of two cathepsins from cod muscle]. 1971 ·PubMed ·(unknown),G. Siebert,(unknown),Maximilian C. C. J. C. Ebert	0

About Maximilian C. C. J. C. Ebert

Maximilian C. C. J. C. Ebert is a scholar working on Sensory Systems, Molecular Medicine and Pharmacology, having authored 23 papers that have together received 706 indexed citations. Recurring topics across this work include Protein Structure and Dynamics (5 papers), Computational Drug Discovery Methods (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Sensory Systems (105 citations), Computational Theory and Mathematics (128 citations) and Pharmacology (60 citations). Maximilian C. C. J. C. Ebert has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Joelle N. Pelletier, Nobuaki Takahashi, Yasuo Mori, Daisuke Kozai, Ryohei Kobayashi, Vicky Mody, Rangaiah Shashidharamurthy, Srujana Rayalam, Guillaume Fortin and Guillaume Lamoureux. Their work appears in journals such as PLoS ONE, Biochemistry and Nature Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact